Dinah Sah Ph.D. is CSO at Voyager Therapeutics, Inc. (VYGR). They have made 1 open-market trade across 1 company since 2018, most recently 2019-01-11.
CIK 0001711043
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VYGR | 163,688 | $309K |
Shares reported on the most recent Form 4, priced at the 2019-01-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VYGR | SELL | 2018-02-27 | 2018-03-01 | $30.00 | $469K | -16.9% | -37.8% | -32.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.